Speakers Abstract
Dr Karen Lim Mei Xian
The work that she will be presenting today is from the EaGeR Trial, which was designed to investigate the feasibility and utility of performing early screening for hyperglycaemia in low-risk pregnant women. Recent results from the TOBOGM study published in the NEJM (2023) showed that early treatment of gestational diabetes before 20 weeks results in a lower incidence of adverse neonatal outcomes. This trial aims to investigate if early screening and treatment of GDM in ‘low-risk’ women and those with a family history of diabetes lowers adverse obstetric and neonatal outcomes.
Dr Karen will present the preliminary results of the EaGeR.
Dr Joshua Dao-Wei Sim
Speakers Biosketch
Dr Karen Lim Mei Xian is a Consultant in the Division of Maternal Fetal Medicine in the Department of Obstetrics and Gynaecology at NUH. Her research endeavors include the care of women with gestational diabetes and prenatal genetic testing and screening. She was a co-investigator in the SPAROW study, a randomized controlled trial on the use of a smartphone app to restore optimal weight in women with recent GDM
Dr Joshua Dao-Wei Sim is a Senior Research Fellow at the Human Potential Translational Research Programme, Yong Loo Lin School of Medicine, National University of Singapore. He is a historian of China-Southeast Asia interactions, with a particular focus on heat health and religion. Some of his publications have appeared in Social Science & Medicine, Healthcare, and Urban Climate. Before becoming a historian, Joshua worked as an exercise scientist in the Singapore Armed Forces. Currently, he is working on projects which profile the heat resilience of Singapore residents through physio-ethnography and oral histories.